LivaNova PLC (LIVN)

Currency in USD
66.47
-0.29(-0.43%)
Real-time Data·
LIVN is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
66.1467.12
52 wk Range
32.4867.92
Key Statistics
Prev. Close
66.76
Open
66.75
Day's Range
66.14-67.12
52 wk Range
32.48-67.92
Volume
218.25K
Average Volume (3m)
616.25K
1-Year Change
38.3063%
Book Value / Share
21.19
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LIVN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
73.00
Upside
+9.82%
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt

LivaNova PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

LivaNova PLC Company Profile

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

LivaNova PLC SWOT Analysis


Innovation Pipeline
Explore LivaNova's product development strategy, focusing on the Essenz heart-lung machine and potential breakthroughs in sleep apnea and depression treatments
Market Dynamics
Delve into LivaNova's positioning in the cardiopulmonary and neuromodulation segments, examining competitive pressures and expansion opportunities
Financial Outlook
Analysts project 6-7% organic growth for LivaNova, with potential to exceed this range. Average price target from analysts stands at $56.50
Regulatory Landscape
Uncover the impact of regulatory decisions on LivaNova's growth prospects, including FDA submissions and Medicare coverage reconsiderations
Read full SWOT analysis

LivaNova PLC Earnings Call Summary for Q3/2025

  • LivaNova exceeded Q3 2025 expectations with EPS of $1.11 (20.65% above forecast) and revenue of $358M, driving a 2.24% pre-market stock increase
  • Revenue grew 13% organically with cardiopulmonary segment up 16% and epilepsy segment up 6%, bolstered by the ESSENCE Heart-Lung Machine launch in China
  • Financial position strengthened with cash balance increasing to $646M from $429M at end-2024, while total debt reduced to $434M from $628M
  • Company raised full-year guidance with organic revenue growth of 9.5-10.5% and adjusted EPS of $3.80-$3.90, despite conservative Q4 outlook
  • Management plans continued investment in Obstructive Sleep Apnea and Depression programs, with potential CMS coverage for depression treatment expected in 2026
Last Updated: 05/11/2025, 14:52
Read Full Transcript

Compare LIVN to Peers and Sector

Metrics to compare
LIVN
Peers
Sector
Relationship
P/E Ratio
−16.7x18.0x−0.6x
PEG Ratio
0.020.170.00
Price/Book
3.1x2.9x2.6x
Price / LTM Sales
2.7x2.6x3.4x
Upside (Analyst Target)
5.8%30.0%44.9%
Fair Value Upside
Unlock10.4%6.3%Unlock

Analyst Ratings

9 Buy
2 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 73.00
(+9.82% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Hold67.00+0.63%58.00Maintain09/01/2026
Stifel
Buy70.00+5.14%65.00Maintain07/01/2026
KeyBanc
Buy81.00+21.66%-New Coverage19/12/2025
Mizuho
Buy72.00+8.14%70.00Maintain17/12/2025
Mizuho
Buy70.00+5.14%65.00Maintain13/11/2025

Earnings

Latest Release
Nov 05, 2025
EPS / Forecast
1.11 / 0.92
Revenue / Forecast
357.80M / 342.70M
EPS Revisions
Last 90 days

People Also Watch

65.37
HAE
-0.62%
18.700
AM
+1.08%
57.44
KLIC
-0.82%
36.08
PACS
+1.91%
670.38
SNDK
+0.77%

FAQ

What Is the LivaNova PLC (LIVN) Share Price Today?

The live LivaNova PLC share price today is 66.47

What Stock Exchange Does LivaNova PLC (LIVN) Trade On?

LivaNova PLC is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for LivaNova PLC?

The stock symbol (also called a 'ticker') for LivaNova PLC is "LIVN."

What Is the Current LivaNova PLC Market Cap?

As of today, LivaNova PLC market capitalisation is 3.64B.

What Is LivaNova PLC's (LIVN) Earnings Per Share (TTM)?

The LivaNova PLC EPS is currently -3.99 (Trailing Twelve Months).

When Is the Next LivaNova PLC Earnings Date?

LivaNova PLC's next earnings report will be released on 25 Feb 2026.

Is LIVN a Buy or Sell From a Technical Analyst Perspective?

Based on today's LivaNova PLC moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has LivaNova PLC Stock Split?

LivaNova PLC has split 0 times. (See the LIVN stock split history page for full effective split date and price information.)

How Many Employees Does LivaNova PLC Have?

LivaNova PLC has 2900 employees.

What is the current trading status of LivaNova PLC (LIVN)?

As of 03 Feb 2026, LivaNova PLC (LIVN) is trading at a price of 66.47, with a previous close of 66.76. The stock has fluctuated within a day range of 66.14 to 67.12, while its 52-week range spans from 32.48 to 67.92.

What Is LivaNova PLC (LIVN) Price Target According to Analysts?

The average 12-month price target for LivaNova PLC is USD73.00, with a high estimate of USD86 and a low estimate of USD64. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +9.82% Upside potential.

What Is the LIVN Premarket Price?

LIVN's last pre-market stock price is 67.51. The pre-market share volume is 50.00, and the stock has decreased by 0.75, or 1.12%.

What Is the LIVN After Hours Price?

LIVN's last after hours stock price is 66.53, the stock has decreased by -0.23, or -0.34%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.